Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Article

Regulation of Vinca alkaloid-induced apoptosis by NF-κB/IκB pathway in human tumor cells

Yi Huang, Yong Fang, Jinmin Wu, Jennifer M. Dziadyk, Xueming Zhu, Meihua Sui and Weimin Fan
Yi Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong Fang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinmin Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer M. Dziadyk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xueming Zhu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meihua Sui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weimin Fan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published March 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Glucocorticoids inhibit Vinca alkaloid-induced DNA fragmentation. BCap37 cells and KB cells were treated with different concentrations of vinblastine (Vinb.) or vincristine (Vinc.) for 48 h with or without pretreatment of 10−7 m TA (Gluco.). Cells were then harvested and fragmented DNA was extracted and analyzed by electrophoresis in 1.2% agarose gel containing 0.1% ethidium bromide.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Glucocorticoids do not affect mitotic arrest induced by Vinca alkaloids. Cells were exposed to 100 nm vinblastine (Vinb.) and vincristine (Vinc.) with or without pretreatment of glucocorticoids (Gluco.) for 24 h before they were harvested for preparation of cytospin slides as described in Materials and Methods. Three hundred cells/slide were counted and only those cells with typical morphological features of condensed chromosomes were identified as mitotically arrested cells. Columns, mean percentage of mitotic cells (independent experiments performed in triplicate); bars, SD.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Vinca alkaloids and glucocorticoids possess opposite effects on IκBα. BCap37 cells were incubated with different concentrations of vinblastine (Vinb.) or vincristine (Vinc.) for 24 h with or without pretreatment of glucocorticoids (10−7 m TA, 24 h; Gluco.). Equal amounts of cellular proteins (50 μg/lane) were fractionated on a 12.5% SDS-PAGE gel and transferred to PVDF membranes followed by immunoblotting with anti-IκBα polyclonal antibody. β-actin proteins were blotted as a control.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Effects of Vinca alkaloids and glucocorticoids on IKK activity. BCap37 cells were treated with the indicated concentrations of vinblastine (Vinb.) or vincristine (Vinc.) for 24 h with or without pretreatment of glucocorticoids (10−7 m TA, 24 h; Gluco.). IKK complex was immunoprecipitated with an anti-IKKα antibody, and the immune complex was subject to in vitro kinase assay (KA) using GST-IκBα fusion protein as the substrate. Following SDS-PAGE, the portion of the gel containing the substrate was dried and processed for autoradiography. The portion containing IKK was analyzed by Western blotting for IKKα protein.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Transfection with antisense IκBα sensitizes Vinca alkaloid-induced apoptosis. BCap37 cells transfected with vector (pcDNA3) only and antisense IκBα (IκBα-ANT5) were incubated with the indicated concentrations of vinblastine (Vinb.) or vincristine (Vinc.) for 48 h. A, DNA fragmentation assays. Cells were harvested and fragmented DNA was analyzed by electrophoresis in 1.2% agarose gel containing 0.1% ethidium bromide. B, MTT assays. Points, mean of three separate experiments; bars, SD. There is a statistically significant difference between antisense IκBα-transfected cells and vector-transfected cells treated by Vinca alkaloids (P < 0.01, Student's t test).

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Vinca alkaloids do not degrade mutant IκBα. Equal amounts of cellular proteins (50 μg/lane) from wild-type BCap37 cells (WT), cells transfected with empty pcDNA3 vector (Vector), and cells transfected with mutant IκBα (Mutant IκBα) treated with different concentrations of vinblastine (A) and vincristine (B) for 24 h were fractionated on 12.5% SDS-PAGE gel and transferred to PVDF membranes followed by immunoblotting with anti-IκBα polyclonal antibody. β-actin protein was used as a control.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Overexpression of mutant IκBα blocks Vinca alkaloid-induced NF-κB activation. BCap37 cells transfected with pcDNA3 vector only (Vector) or mutant IκBα (Mutant IκBα) were treated with different concentrations of vinblastine (Vinb.; A) and vincristine (Vinc.; B) for 24 h. Equal amounts of nuclear cell extracts were subjected to EMSAs with [γ-32P]-labeled oligonucleotide encompassing the NF-κB binding site. NS, nonspecific site.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Overexpression of mutant IκBα suppresses vinblastine- and vincristine-induced apoptosis. Wild-type BCap37 cells (WT) and cells transfected with pcDNA3 vector only (Vector) or mutant IκBα (Mutant IκBα) were treated with 50 or 100 nm vinblastine (A) and vincristine (B) for 48 h. Cells were harvested and stained with propidium iodide for flow cytometric analysis. The peaks corresponding to G1 and G2-M phases of the cell cycle are indicated. The sub-G1 peaks (AP) represent apoptotic cells.

PreviousNext
Back to top
Molecular Cancer Therapeutics: 3 (3)
March 2004
Volume 3, Issue 3
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Regulation of Vinca alkaloid-induced apoptosis by NF-κB/IκB pathway in human tumor cells
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Regulation of Vinca alkaloid-induced apoptosis by NF-κB/IκB pathway in human tumor cells
Yi Huang, Yong Fang, Jinmin Wu, Jennifer M. Dziadyk, Xueming Zhu, Meihua Sui and Weimin Fan
Mol Cancer Ther March 1 2004 (3) (3) 271-277;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Regulation of Vinca alkaloid-induced apoptosis by NF-κB/IκB pathway in human tumor cells
Yi Huang, Yong Fang, Jinmin Wu, Jennifer M. Dziadyk, Xueming Zhu, Meihua Sui and Weimin Fan
Mol Cancer Ther March 1 2004 (3) (3) 271-277;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers
  • Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non–small cell lung cancer cells (H1299)
  • Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells
Show more Article
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement